When there are impactful studies and advancements in care strategies and technology, then the guidelines get completely rewritten. This acts as an amendment to the original. When the committees see one or a few potential changes to one or more sections of the guidelines, they may release a focused update, depending on the critical nature of the information. Guidelines should reflect up-to-date knowledge, technology, current recommendations, and treatment options, so that optimum medical care can be provided. The American College of Cardiology Foundation and The American Heart Association Task Force on Practice Guidelines (ACCF/AHA) are constantly monitoring new study results, medications, and devices that merit modifications to existing clinical practice guidelines. That requires keeping up with changing guidelines and technology in cardiovascular care.Д®ven when clinicians find the appropriate therapeutic balance, patient adherence or financial constraints can topple the plan. After placement of a coronary stent, the care team has to perform a careful balancing act between the risk of an ischemic event, bleeding, and stent thrombosis using dual antiplatelet therapy (DAPT). Finding that equilibrium can be particularly challenging in cardiovascular medicine. Medication safety can sometimes be a tightrope walk of balancing various risks against potential benefits. Follow events and discussions at #HeartMonth.ДЄuthor:В William Alvarez, Jr., PharmD, BCPS, and David Boyce

Stent with guideliner